72
Views
1
CrossRef citations to date
0
Altmetric
Research Article

A systematic review and meta-analysis of the association of transforming growth factor β receptor I 6A/9A gene polymorphism with ovarian cancer risk

, , , , , , , & show all
Pages 313-316 | Received 20 Dec 2013, Accepted 02 Jan 2014, Published online: 10 Feb 2014

References

  • Abdallah BY, Horne SD, Kurkinen M, et al. Ovarian cancer evolution through stochastic genome alterations: defining the genomic role in ovarian cancer. Syst Biol Reprod Med 2014;60:2–13
  • Heubner M, Wimberger P, Kasimir-Bauer S, et al. The AA genotype of a L1C G842A polymorphism is associated with an increased risk for ovarian cancer. Anticancer Res 2009;29:3449–52
  • Kontorovich T, Levy A, Korostishevsky M, et al. Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women. Int J Cancer 2010;127:589–97
  • Terry KL, Tworoger SS, Gates MA, et al. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk. Carcinogenesis 2009;30:2042–6
  • Zhou TB, Guo XF, Yin SS. Association of peroxisome proliferator-activated receptor gamma Pro12Ala gene polymorphism with type 2 diabetic nephropathy risk in Caucasian population. J Recept Signal Transduct Res 2013 (Epub ahead of print)
  • Zhou TB, Yin SS, Jiang ZP. Association of angiotensin II type-1 receptor A1166C gene polymorphism with the susceptibility of end-stage renal disease. J Recept Signal Transduct Res 2013;33:325–31
  • Zhou TB, Xu HL, Yin SS. Association between endothelial nitric oxide synthase Glu298Asp gene polymorphism and diabetic nephropathy susceptibility. Ren Fail 2013;35:173–8
  • Hou YL, Chen H, Dong ZH, et al. Clinical significance of serum transforming growth factor-beta1 in lung cancer. Cancer Epidemiol 2013;37:750–3
  • Zhou TB, Qin YH, Lei FY, et al. apoE expression in glomerulus and correlation with glomerulosclerosis induced by adriamycin in rats. Ren Fail 2011;33:348–54
  • Spillman MA, Schildkraut JM, Halabi S, et al. Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk. Gynecol Oncol 2005;97:543–9
  • Zhou TB, Qin YH, Su LN, et al. The association between angiotensin-converting enzyme insertion/deletion gene variant and risk of focal segmental glomerulosclerosis: a systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst 2011;12:624–33
  • Zhou TB, Qin YH, Su LN, et al. Insertion/deletion (I/D) polymorphism of angiotensin-converting enzyme gene in steroid-resistant nephrotic syndrome for children: a genetic association study and meta-analysis. Ren Fail 2011;33:741–8
  • Pasche B, Kolachana P, Nafa K, et al. TbetaR-I(6A) is a candidate tumor susceptibility allele. Cancer Res 1999;59:5678–82
  • Baxter SW, Choong DY, Eccles DM, Campbell IG. Transforming growth factor beta receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev 2002;11:211–4
  • Jakubowska A, Gronwald J, Menkiszak J, et al. BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. Breast Cancer Res Treat 2010;119:201–11

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.